SCHOTT Pharma AG & Co. KGaA (VIE:1SXP)
Austria · Delayed Price · Currency is EUR 14.92
-0.04 (-0.27%)
Last updated: Dec 23, 2025, 8:55 AM CET
VIE:1SXP Revenue
In the fiscal year ending September 30, 2025, SCHOTT Pharma AG & Co. KGaA had annual revenue of 986.21M EUR with 3.04% growth. SCHOTT Pharma AG & Co. KGaA had revenue of 247.58M in the quarter ending September 30, 2025, with 4.44% growth.
Revenue
986.21M
Revenue Growth
+3.04%
P/S Ratio
2.28
Revenue / Employee
209.12K
Employees
4,811
Market Cap
2.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 986.21M | 29.12M | 3.04% |
| Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
| Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
| Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
| Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| OMV Aktiengesellschaft | 31.89B |
| Strabag SE | 17.92B |
| Voestalpine AG | 15.29B |
| Vienna Insurance Group AG | 13.13B |
| Erste Group Bank AG | 10.96B |
| Raiffeisen Bank International AG | 8.90B |
| VERBUND AG | 8.30B |
| Andritz AG | 7.84B |